BridgeMD
New treatment option for Anemia, Iron Deficiency
Official title Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron Status
ClinicalTrials.gov ID: NCT06568315
What this study is testing
- What it's testing
- The World Health Organization (WHO) currently recommends the pregnant women receive iron-containing supplements and, in settings where calcium intake is low, calcium supplements. Supplements are to be taken at two separate times of the day as calcium may interfere with iron absorption.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Burkina Faso: married or unmarried pregnant women aged ≥15 years
- Pakistan: married pregnant women ≥18 years
- Willing to receive all antenatal care at a study clinic
- Willing to stop iron folic acid supplementation to receive the study intervention
- Hb ≥70 g/L
You likely can't join if
- Burkina Faso: \<15 years or unmarried pregnant women \<18 years without consent from parent / guardian
- Pakistan: pregnant women \<18 years.
- Unwilling to receive antenatal care at a study clinic
- Unwilling to stop iron folic acid supplementation to receive the study intervention
- Hemoglobin \< 70 g/L
- \<6 weeks of gestation or ≥20 weeks of gestation
See the full eligibility criteria
- Burkina Faso: married or unmarried pregnant women aged ≥15 years
- Pakistan: married pregnant women ≥18 years
- Willing to receive all antenatal care at a study clinic
- Willing to stop iron folic acid supplementation to receive the study intervention
- Hb ≥70 g/L
- 6\<20 weeks of gestation based on fetal ultrasound
- Burkina Faso: \<15 years or unmarried pregnant women \<18 years without consent from parent / guardian
- Pakistan: pregnant women \<18 years.
- Unwilling to receive antenatal care at a study clinic
- Unwilling to stop iron folic acid supplementation to receive the study intervention
- Hemoglobin \< 70 g/L
- \<6 weeks of gestation or ≥20 weeks of gestation
- Non-viable or extrauterine pregnancy
- Any contraindications to study supplements
The study team makes the final eligibility decision.
Where it's taking place
- Ouagadougou, Burkina Faso
- Karachi, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 15 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ouagadougou, Burkina Faso; Karachi, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.